Basel, Switzerland, August 21, 2013 --(PR.com
)-- International Medical Ventures, Inc., an early stage life science venture capital company, is pleased to announce they will be attending The 2nd International Conference on Genomics in the Americas. The show is put on by BGI, the largest genomics center in the world and will take place on 12 and 13 September, 2013 at the Hyatt Regency in Sacramento.
The conference - regarded as one the top scientific gathering for genome sciences - is designed to share ground-breaking research in basic and applied genomics and to advance new approaches to sequencing and bioinformatics.
“We’re honored to be attendees at The 2nd International Conference on Genomics and are very much looking forward to interact directly with other genomics industry luminaries, as well as scientific thought leaders and top pharmaceutical executives while at the conference,” said Helge Amacker, Director of Business Development.
International Medical Ventures is currently in the initial phase of building its full service international clinical trial organization (CRO) which will provide tests for the BRCA marker as well as drug development and therapeutic solutions. To learn more about International Medical Ventures, please visit www.imedvt.com.
About International Medical Ventures, Inc. (IMV)
International Medical Ventures is a Swiss based firm which leads or manages private equity and venture investments in biotechnology, medical device companies and healthcare services in all stages of developments. The company has established relationships with some of the industry’s leading institutions to offer emerging companies and investors opportunities in unique new businesses.